Paul Lammers

Paul Lammers

Company: Triumvira Immunologics

Job title: President & Chief Executive Officer


Clinical Trial Updates for TAC Technology 4:00 pm

Elucidating the difference between TAC technology and other cell therapies Providing updates of clinical developments Using clinical to data to inform the future of phase I and II trialsRead more

day: Day Two

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.